Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States
KELOWNA, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Month: August 2021
Olainfarm invites to Second Quarter 2021 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on August...
Orphazyme to host Interim Report First Half 2021 investor call on August 31, 2021
Orphazyme A/SInvestor news No. 08/2021Company Registration No. 32266355 Copenhagen – August 25, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical...
BBS-Bioactive Bone Substitutes Plc: CORRECTION: Half-Year Report January 1st –June 30th 2021 (Unaudited)
BBS-Bioactive Bone Substitutes Plc’s Company Release August 25th 03.30 p.m. BBS-Bioactive Bone Substitutes Plc corrects its company release published August 25th at 12.45...
BioSyent Releases Q2 and H1 2021 Financial Results
MISSISSAUGA, Ontario, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for...
Canary Medical to Present Data at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
VANCOUVER, British Columbia and CARLSBAD, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on...
Achilles Therapeutics Announces Grant of US and European Patents
LONDON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2
VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an...
New Study Confirms Sientra’s AlloX2’s Unique Value in Managing Seroma and Infection Post Reconstruction Procedures
SANTA BARBARA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company...
Connect Biopharma to Host First Half 2021 Financial Results Conference Call on September 1, 2021
SAN DIEGO and TAICANG, SUZHOU, China, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma"...
Arcutis Enrolls First Patient in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Scalp and Body Psoriasis
Topical roflumilast potential “Best-in-Class” topical PDE4 inhibitorScalp and body psoriasis affects more than 8 million patients in the U.S.WESTLAKE VILLAGE,...
CytoDyn’s Final mTNBC Report Indicates as Much as 980% Increase in 12-Month Overall Survival and Up to 660% in 12-Month Modified Progression Free Survival
Decreases in Circulating Tumor Cells after leronlimab induction were seen in 73% of the patients and associated with increase in...
Ann Zieser Joins PetVivo Holdings, Inc. as Senior Technical Veterinarian
PetVivo Holdings, Inc. Dr. Ann Zieser Joins PetVivo Holdings, Inc. as Senior Technical Veterinarian MINNEAPOLIS, MN, US, Aug. 25, 2021...
Context Therapeutics® and Tyligand Bioscience Reach ONA-XR Manufacturing Optimization Milestone
PHILADELPHIA and SHANGHAI, China, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (the “Company”), a women’s oncology company developing...
Flexion Therapeutics Announces Expansion of Phase 1b Trial Investigating FX301 for the Management of Post-Operative Pain
Initial findings from proof-of-concept trial in patients undergoing bunionectomy support expansion of the study to include 36 additional patientsData from...
XRad Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of XRD-0394 for Metastatic, Locally-Advanced or Recurrent Solid Tumors
- Study to evaluate the safety and tolerability of XRD-0394 in combination with palliative radiation therapy - Major milestone for...
Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac...
Anatomage Spins Out its 3D Dental Technology Business As Osteoid
A wholly owned subsidiary, Osteoid to focus on its award-winning Invivo solutions and add new capabilities to power the future of digital...
FibroGen Announces Positive Topline Results from Phase 2 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia
SAN FRANCISCO, Aug. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced positive topline results from WHITNEY, the...
Agra Ventures Announces Details of Share Consolidation
The Company’s Common Shares Are Expected to Begin Trading With New CUSIP and ISIN Numbers on or about August 27,...
